Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Microbot Medical Inc. (MBOT) Stock Forecast 2025 - AI Price Prediction & Analysis

Microbot Medical Inc. (MBOT) AI Stock Price Forecast & Investment Analysis

Microbot Medical Inc. Stock Price Chart and Technical Analysis

Loading Microbot Medical Inc. interactive price chart and technical analysis...

Microbot Medical Inc. (MBOT) - Comprehensive Stock Analysis & Investment Research

Deep dive into Microbot Medical Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Microbot Medical Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Microbot Medical Inc.: Microbot Medical Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Microbot Medical Inc. (Stock Symbol: MBOT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 29 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Microbot Medical Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Microbot Medical Inc.:

Market Capitalization: $85 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -71.4% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Microbot Medical Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Microbot Medical Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Microbot Medical Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Microbot Medical Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Microbot Medical Inc.: Market positioning analysis based on available financial and operational metrics.

Microbot Medical Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 645.6% gross margin, indicating strong pricing power and operational efficiency.

Microbot Medical Inc. (MBOT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Microbot Medical Inc. stock analysis.

Loading Microbot Medical Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Microbot Medical Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Microbot Medical Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Microbot Medical Inc.: With a P/E ratio of -1.32, the market sees the stock as potentially undervalued.

P/E Ratio -1.32x
P/B Ratio 2.79x
Market Cap $85M
EPS $-0.58
Book Value/Share $0.80
Revenue/Share $-0.48
FCF/Share $-1.21
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Microbot Medical Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Microbot Medical Inc.: An ROE of -71.4% indicates room for improvement in shareholder value creation.

ROE -71.4%
ROA -64.0%
ROIC -68.5%
Gross Margin 645.6%
Operating Margin -31426.7%
Net Margin -26906.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Microbot Medical Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Microbot Medical Inc.: A current ratio of 7.61 indicates strong liquidity.

Current Ratio 7.61x
Quick Ratio 7.44x
D/E Ratio 0.03x
Financial Leverage 1.18x
Interest Coverage -228.3x
Working Capital $24M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Microbot Medical Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Microbot Medical Inc.: Free cash flow of $-10M indicates cash challenges that need attention.

Operating Cash Flow $-10M
Free Cash Flow $-10M
CapEx/Sales 901.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Microbot Medical Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Microbot Medical Inc.: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Receivables Turnover 1.5x
Fixed Assets Turnover 0.0x
Days Sales Outstanding 249 days
Payables Period 277 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Microbot Medical Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Microbot Medical Inc.:

Income Statement ($ Millions)
R&D Expense $6M
SG&A Expense $739M
Cost of Goods Sold $-8M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 93%
Cash & Short-term Investments 91%
Total Liabilities 15%
Short-term Debt 7%
Accounts Receivable 1%
Dividend & Shareholder Information
Shares Outstanding 38M
Growth Metrics (YoY)
EPS Growth -58.0%

Latest Microbot Medical Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Microbot Medical Inc. (MBOT) stock price and investment outlook.

📰 We are currently updating our news feed for Microbot Medical Inc.. Check back soon for the latest market analysis and company updates.

Microbot Medical Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Microbot Medical Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $17M x 1.9x
ALUR Unlock Forecast - 30 Days FREE Trial $15M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $499M -1.4x 2.8x
ANIK Unlock Forecast - 30 Days FREE Trial $140M -4.3x 1.0x
AORT Unlock Forecast - 30 Days FREE Trial $2019M -198.2x 4.8x
APYX Unlock Forecast - 30 Days FREE Trial $111M -3.5x 15.3x
ARAY Unlock Forecast - 30 Days FREE Trial $160M -9.9x 2.0x
ATEC Unlock Forecast - 30 Days FREE Trial $2836M -7.4x 246.5x
ATRC Unlock Forecast - 30 Days FREE Trial $1718M -39.6x 3.6x
AVHHL Unlock Forecast - 30 Days FREE Trial $30M x x
BAX Unlock Forecast - 30 Days FREE Trial $9360M -94.9x 1.3x
BBNX Unlock Forecast - 30 Days FREE Trial $1197M x 4.1x
BDX Unlock Forecast - 30 Days FREE Trial $51185M 34.1x 2.0x
BEAT Unlock Forecast - 30 Days FREE Trial $59M -5.7x 14.1x
BJDX Unlock Forecast - 30 Days FREE Trial $3M -0.5x 0.6x
BSX Unlock Forecast - 30 Days FREE Trial $147293M 61.0x 6.3x
BVS Unlock Forecast - 30 Days FREE Trial $450M -18.3x 2.8x
CARL Unlock Forecast - 30 Days FREE Trial $59M x x
CERS Unlock Forecast - 30 Days FREE Trial $278M -13.8x 5.0x
CLPT Unlock Forecast - 30 Days FREE Trial $660M -23.5x 33.4x
CODX Unlock Forecast - 30 Days FREE Trial $17M -0.7x 0.4x
CTSO Unlock Forecast - 30 Days FREE Trial $49M -1.8x 4.2x
CVRX Unlock Forecast - 30 Days FREE Trial $266M -5.5x 4.6x
DCTH Unlock Forecast - 30 Days FREE Trial $344M 160.2x 3.3x
DRIO Unlock Forecast - 30 Days FREE Trial $625M 0.6x 9.8x
DRTS Unlock Forecast - 30 Days FREE Trial $354M x 4.1x
DXCM Unlock Forecast - 30 Days FREE Trial $23568M 49.1x 8.6x
EBRCZ Unlock Forecast - 30 Days FREE Trial $427M x 8.6x
EMBC Unlock Forecast - 30 Days FREE Trial $780M 15.8x -0.8x
FEMY Unlock Forecast - 30 Days FREE Trial $23M -1.4x 15.2x
FOFA Unlock Forecast - 30 Days FREE Trial $15M x 26.3x
GIPL Unlock Forecast - 30 Days FREE Trial $7M x 36.1x
GKOS Unlock Forecast - 30 Days FREE Trial $5015M -46.3x 6.5x
GMED Unlock Forecast - 30 Days FREE Trial $8454M 24.1x 2.0x
GUTS Unlock Forecast - 30 Days FREE Trial $60M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $2408M 26.1x 2.7x
HRGN Unlock Forecast - 30 Days FREE Trial $31M x 40.4x
IART Unlock Forecast - 30 Days FREE Trial $920M 200.2x 0.9x
ICCM Unlock Forecast - 30 Days FREE Trial $43M x 14.9x
ICUI Unlock Forecast - 30 Days FREE Trial $3033M -49.8x 1.4x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $22M x 5.0x
IINNW Unlock Forecast - 30 Days FREE Trial $10M x 2.4x
INBS Unlock Forecast - 30 Days FREE Trial $8M -0.3x 2.7x
INFU Unlock Forecast - 30 Days FREE Trial $206M 40.8x 3.8x
INSP Unlock Forecast - 30 Days FREE Trial $2131M 43.2x 3.1x
IRMD Unlock Forecast - 30 Days FREE Trial $977M 48.3x 10.4x
IRTC Unlock Forecast - 30 Days FREE Trial $5958M -20.2x 48.9x
KIDS Unlock Forecast - 30 Days FREE Trial $394M -20.7x 1.1x
KMTS Unlock Forecast - 30 Days FREE Trial $1406M x x
KRMD Unlock Forecast - 30 Days FREE Trial $183M -19.8x 11.1x
LMAT Unlock Forecast - 30 Days FREE Trial $1983M 43.4x 5.5x
LNSR Unlock Forecast - 30 Days FREE Trial $147M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $122M -0.6x 15.5x
LUNG Unlock Forecast - 30 Days FREE Trial $74M -4.3x 1.1x
MBOT Unlock Forecast - 30 Days FREE Trial $85M -1.3x 2.8x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDAI Unlock Forecast - 30 Days FREE Trial $52M -1.3x -42.3x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $1133M 30.5x 4.7x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $86159M 26.8x 18.6x
MMSI Unlock Forecast - 30 Days FREE Trial $5178M 41.1x 3.4x
MODD Unlock Forecast - 30 Days FREE Trial $31M -2.1x 2.6x
NEPH Unlock Forecast - 30 Days FREE Trial $59M 39.1x 7.1x
NMTC Unlock Forecast - 30 Days FREE Trial $39M -1.7x 4.7x
NPCE Unlock Forecast - 30 Days FREE Trial $328M -10.4x 16.9x
NSPR Unlock Forecast - 30 Days FREE Trial $75M -4.3x 3.7x
NUMD Unlock Forecast - 30 Days FREE Trial $3M x x
NVCR Unlock Forecast - 30 Days FREE Trial $1434M -20.8x 4.2x
NXGL Unlock Forecast - 30 Days FREE Trial $20M -6.8x 4.3x
OBIO Unlock Forecast - 30 Days FREE Trial $147M -3.4x 1.5x
OFIX Unlock Forecast - 30 Days FREE Trial $610M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $13M x 0.2x
OSUR Unlock Forecast - 30 Days FREE Trial $202M 17.1x 0.5x
PAVM Unlock Forecast - 30 Days FREE Trial $10M 0.1x 0.3x
PDEX Unlock Forecast - 30 Days FREE Trial $111M 10.3x 2.7x
PEN Unlock Forecast - 30 Days FREE Trial $8870M 67.4x 6.9x
PETV Unlock Forecast - 30 Days FREE Trial $36M -1.4x 9.6x
PLRZ Unlock Forecast - 30 Days FREE Trial $6M x 0.3x
PLSE Unlock Forecast - 30 Days FREE Trial $1139M -2.6x 10.9x
PMI Unlock Forecast - 30 Days FREE Trial $26M x x
PODD Unlock Forecast - 30 Days FREE Trial $22518M 97.8x 15.4x
PRCT Unlock Forecast - 30 Days FREE Trial $1891M -45.4x 4.9x
PROF Unlock Forecast - 30 Days FREE Trial $182M x 4.7x
PSTV Unlock Forecast - 30 Days FREE Trial $68M -0.3x 13.4x
PYPD Unlock Forecast - 30 Days FREE Trial $60M x 2.9x
RCEL Unlock Forecast - 30 Days FREE Trial $99M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $34M x 12.9x
RMD Unlock Forecast - 30 Days FREE Trial $36332M 27.7x 5.9x
RSMDF Unlock Forecast - 30 Days FREE Trial $3625M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $27M -0.9x 0.4x
SGHT Unlock Forecast - 30 Days FREE Trial $261M -3.7x 3.7x
SIBN Unlock Forecast - 30 Days FREE Trial $638M -14.3x 3.8x
SKIN Unlock Forecast - 30 Days FREE Trial $181M -1.8x 2.5x
SNOA Unlock Forecast - 30 Days FREE Trial $6M -5.6x 1.6x
SNWV Unlock Forecast - 30 Days FREE Trial $248M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $11811M 32.9x 3.2x
SRTS Unlock Forecast - 30 Days FREE Trial $51M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $7M -8.0x 24.1x
STIM Unlock Forecast - 30 Days FREE Trial $175M -1.0x 6.5x
STME Unlock Forecast - 30 Days FREE Trial $20M x x
STSS Unlock Forecast - 30 Days FREE Trial $5M -2.5x 0.3x
SYK Unlock Forecast - 30 Days FREE Trial $138429M 50.7x 11.8x
TCMD Unlock Forecast - 30 Days FREE Trial $336M 22.3x 1.7x
TELA Unlock Forecast - 30 Days FREE Trial $49M -1.8x 5.3x
TFX Unlock Forecast - 30 Days FREE Trial $5543M 31.0x 1.3x
TLSI Unlock Forecast - 30 Days FREE Trial $180M -3.6x -5.6x
TMCI Unlock Forecast - 30 Days FREE Trial $402M -7.5x 4.1x
TNDM Unlock Forecast - 30 Days FREE Trial $945M -17.1x 7.1x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.4x
UFPT Unlock Forecast - 30 Days FREE Trial $1499M 44.7x 3.9x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $187M 15.5x 1.6x
VERO Unlock Forecast - 30 Days FREE Trial $4M 0.0x 1.8x
WST Unlock Forecast - 30 Days FREE Trial $20116M 44.4x 6.6x
XAIR Unlock Forecast - 30 Days FREE Trial $10M -0.3x 1.0x
XTNT Unlock Forecast - 30 Days FREE Trial $111M -478.8x 2.3x

Frequently Asked Questions - Microbot Medical Inc. Stock Forecast

How accurate are Microbot Medical Inc. stock predictions?

Our AI model shows a 32% Spearman correlation coefficient for MBOT predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Microbot Medical Inc. stock price forecasts?

Our analysis considers Microbot Medical Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Microbot Medical Inc. a good investment in 2025?

Based on our AI analysis, Microbot Medical Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Microbot Medical Inc. forecasts updated?

Microbot Medical Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Microbot Medical Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Microbot Medical Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...